[HTML][HTML] Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA

…, PM Bath, Q Dong, A Xu, J Jing, J Lin… - … England Journal of …, 2021 - Mass Medical Soc
Background Comparisons between ticagrelor and clopidogrel for the secondary prevention
of stroke in CYP2C19 loss-of-function carriers have not been extensively performed. …

Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack

Y Wang, X Zhao, J Lin, H Li, SC Johnston, Y Lin, Y Pan… - Jama, 2016 - jamanetwork.com
Importance Data are limited regarding the association betweenCYP2C19genetic variants
and clinical outcomes of patients with minor stroke or transient ischemic attack treated with …

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient …

…, X Meng, Y Pan, Y Wang, X Zhao, J Lin… - Stroke and vascular …, 2019 - svn.bmj.com
Background and purpose Stroke is the leading cause of mortality and disability in China.
Precise aetiological classification, imaging and biological markers may predict the prognosis of …

Dual antiplatelet treatment up to 72 hours after ischemic stroke

…, Y Yang, T Wang, S Han, X Meng, J Lin… - … England Journal of …, 2023 - Mass Medical Soc
Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤24 hours) after an acute …

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint …

Y Wang, W Chen, Y Lin, X Meng, G Chen, Z Wang… - bmj, 2019 - bmj.com
Objective To test the hypothesis that ticagrelor plus aspirin is safe and superior to clopidogrel
plus aspirin for reducing high platelet reactivity at 90 days and stroke recurrence in patients …

[HTML][HTML] Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study

J Li, J Lin, Y Pan, M Wang, X Meng, H Li… - Journal of …, 2022 - Springer
Objective Contribution of individual and combined inflammatory markers in prognosis after
stroke was still undefined. We aimed to investigate the association of systemic and local …

High-sensitive C-reactive protein predicts recurrent stroke and poor functional outcome: subanalysis of the clopidogrel in high-risk patients with acute nondisabling …

J Li, X Zhao, X Meng, J Lin, L Liu, C Wang, A Wang… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Minor stroke and transient ischemic attack are common
disorders with high rate of subsequent disabling stroke. We aim to investigate the role of high-…

[HTML][HTML] The STROMICS genome study: deep whole-genome sequencing and analysis of 10K Chinese patients with ischemic stroke reveal complex genetic and …

…, Z Xu, S Bian, X Chen, Y Shi, Y Li, Y Duan, Y Liu, J Lin… - Cell Discovery, 2023 - nature.com
Ischemic stroke is a leading cause of global mortality and long-term disability. However, there
is a paucity of whole-genome sequencing studies on ischemic stroke, resulting in limited …

[HTML][HTML] Residual inflammatory risk predicts poor prognosis in acute ischemic stroke or transient ischemic attack patients

…, J Xu, S Li, M Wang, K Quan, X Meng, H Li, J Lin… - Stroke, 2021 - journals.lww.com
Background and Purpose: It is still unclear whether the residual cholesterol and inflammatory
risk in the acute phase is associated with prognosis of stroke. We aimed to investigate the …

Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke

J Lin, H Zheng, BL Cucchiara, J Li, X Zhao, X Liang… - Neurology, 2015 - AAN Enterprises
Objective: To determine the association of lipoprotein-associated phospholipase A 2 (Lp-PLA
2 ) measured in the acute period and the short-term risk of recurrent vascular events in …